Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dechloro teicoplanin antibiotics.

A Malabarba1, F Spreafico, P Ferrari

  • 1Merrell Dow Research Institute, Lepetit Research Center, Gerenzano, Italy.

The Journal of Antibiotics
|November 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessment of Clinical and Neurological Alterations Before Radiation Therapy in Children With Malignant Brain Tumours.

Clinical oncology (Royal College of Radiologists (Great Britain))·2025
Same author

Higher testosterone is associated with increased inflammatory markers in women with SARS-CoV-2 pneumonia: preliminary results from an observational study.

Journal of endocrinological investigation·2021
Same author

Fifty years of clinical and research studies for childhood renal tumors within the International Society of Pediatric Oncology (SIOP).

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

High dose chemotherapy and autologous hematopoietic cell transplantation for Wilms tumor: a study of the European Society for Blood and Marrow Transplantation.

Bone marrow transplantation·2019
Same author

Quality of life in long-term survivors treated for metastatic medulloblastoma with a hyperfractionated accelerated radiotherapy (HART) strategy.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery·2017
Same author

Possible role of pandemic AH1N1 swine flu virus in a childhood leukemia cluster.

Leukemia·2017

Researchers selectively removed chlorine from teicoplanin antibiotics, studying the process and its impact on antibacterial activity. This research offers insights into modifying these crucial drugs for potential therapeutic benefits.

Area of Science:

  • Medicinal Chemistry
  • Antibiotic Research
  • Organic Synthesis

Background:

  • Teicoplanin is a critical glycopeptide antibiotic used against Gram-positive bacteria.
  • Understanding the structure-activity relationship of teicoplanin is essential for developing new antibiotics.
  • Selective dehalogenation offers a method to probe the role of specific chemical groups.

Purpose of the Study:

  • To prepare mono- and didechlorinated derivatives of teicoplanin and related compounds.
  • To investigate the selectivity and kinetics of reductive dehalogenation.
  • To evaluate the impact of chlorine substituents on the mechanism of action and antibacterial efficacy.

Main Methods:

  • Selective reductive dehalogenation of teicoplanin, pseudoaglycones, aglycone, and deglucoteicoplanin derivatives.

Related Experiment Videos

  • Comparative kinetic studies of dehalogenation with vancomycin and deglucovancomycin.
  • Assessment of antibacterial activity and mechanism of action of the modified compounds.
  • Main Results:

    • Successfully synthesized mono- and didechlorinated teicoplanin derivatives under selective reductive conditions.
    • Characterized the selectivity and rates of dehalogenation, comparing them to vancomycin analogues.
    • Observed alterations in antibacterial activity and mechanism of action due to chlorine substitution.

    Conclusions:

    • Selective reductive dehalogenation is a viable method for modifying teicoplanin antibiotics.
    • Chlorine substituents significantly influence the antibacterial properties and mechanism of action of teicoplanin.
    • This study provides a foundation for designing novel teicoplanin-based antibiotics with improved characteristics.